Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · IEX Real-Time Price · USD
2.000
+0.140 (7.53%)
Apr 23, 2024, 4:00 PM EDT - Market closed
Cognition Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CGTX stock have an average target of 6.67, with a low estimate of 5.00 and a high estimate of 9.00. The average target predicts an increase of 233.50% from the current stock price of 2.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CGTX stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +150.00% | Mar 28, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $9 | Buy | Maintains | $9 | +350.00% | Mar 27, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $10 → $6 | Strong Buy | Maintains | $10 → $6 | +200.00% | Aug 14, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $9 | Buy | Reiterates | $9 | +350.00% | May 9, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $9 | Buy | Reiterates | $9 | +350.00% | Mar 24, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.99
from -0.86
EPS Next Year
-1.22
from -0.99
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 44.0M | 92.4M |
| Avg | n/a | n/a | n/a | 10.7M | 44.9M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 764.2% |
| Avg | - | - | - | - | 319.8% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -0.65 | -0.62 | -0.89 | -2.89 |
| Avg | -0.99 | -1.22 | -1.85 | -2.81 |
| Low | -1.31 | -1.80 | -2.73 | -2.70 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.